title: The three-step pretargeting approach reduces the human anti-mouse antibody response in patients submitted to radioimmunoscintigraphy and radioimmunotherapy.
authors.forename: G
authors.initials: G
authors.lastname: Paganelli
authors.forename: M
authors.initials: M
authors.lastname: Chinol
authors.forename: M
authors.initials: M
authors.lastname: Maggiolo
authors.forename: A
authors.initials: A
authors.lastname: Sidoli
authors.forename: A
authors.initials: A
authors.lastname: Corti
authors.forename: S
authors.initials: S
authors.lastname: Baroni
authors.forename: A G
authors.initials: AG
authors.lastname: Siccardi
mesh_terms: D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000276:immunology*; D001360:Avidin / Q000276:immunology; D001426:Bacterial Proteins / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D051379:Mice; D016719:Radioimmunodetection; D016499:Radioimmunotherapy; D019809:Streptavidin
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D001426:Bacterial Proteins; D001360:Avidin; D019809:Streptavidin